SCH-217,443
SCH-217,443
SCH-217,443 is a chemical compound that has been studied for its potential pharmacological effects. It is primarily known for its role as a selective antagonist of the serotonin 5-HT6 receptor, which is a target of interest in the development of treatments for cognitive disorders and other neurological conditions.
Chemical Structure and Properties[edit | edit source]
SCH-217,443 is a synthetic compound with a complex molecular structure. The chemical formula for SCH-217,443 is C21H26N2O2, and it has a molecular weight of 338.45 g/mol. The compound is characterized by its specific binding affinity to the 5-HT6 receptor, which is a G protein-coupled receptor predominantly found in the central nervous system.
Pharmacological Action[edit | edit source]
The primary action of SCH-217,443 is as a selective antagonist of the 5-HT6 receptor. This receptor is involved in the modulation of neurotransmitter release, including acetylcholine, dopamine, and glutamate, which are critical for cognitive processes such as learning and memory. By blocking the 5-HT6 receptor, SCH-217,443 has been shown to enhance cognitive function in preclinical studies.
Research and Development[edit | edit source]
Research into SCH-217,443 has focused on its potential therapeutic applications in treating cognitive impairments associated with conditions such as Alzheimer's disease and schizophrenia. Preclinical studies have demonstrated that SCH-217,443 can improve performance in animal models of memory and learning deficits.
Clinical Trials[edit | edit source]
As of the latest updates, SCH-217,443 has undergone various phases of clinical trials to assess its safety, tolerability, and efficacy in humans. These trials aim to determine the potential of SCH-217,443 as a treatment for cognitive disorders. However, detailed results and the current status of these trials should be consulted from the latest scientific literature and clinical trial registries.
Potential Side Effects[edit | edit source]
Like many pharmacological agents, SCH-217,443 may have side effects. Commonly reported side effects in clinical trials include headache, nausea, and dizziness. The safety profile of SCH-217,443 continues to be evaluated in ongoing research.
Also see[edit | edit source]
 | This article about a biochemical receptor is a stub. You can help WikiMD by expanding it. |
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
